TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/23 21:42 | 1/3/23 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Ekman Lars | CA | DH | Chair of | S.d | -886 | 55.98 | 0 | -16 | -98 | 0 | D | ||||||||||||||
12/2/22 21:30 | 12/1/22 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Ekman Lars | CA | DH | Chair of | S.d | -975 | 61.60 | 0 | -16 | -98 | 0 | D | ||||||||||||||
11/3/22 21:31 | 11/1/22 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Ekman Lars | CA | DH | Chair of | S.d | -996 | 62.89 | 0 | -16 | -98 | 0 | D | ||||||||||||||
10/5/22 21:46 | 10/3/22 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Ekman Lars | CA | DH | Chair of | S.d | -974 | 61.52 | 0 | -16 | -98 | 0 | D | ||||||||||||||
9/30/22 21:30 | 9/28/22 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Ekman Lars | CA | DH | Chair of | S.d | -1,523 | 48.09 | 0 | -32 | -99 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |